SPY326.97-3.68 -1.11%
DIA271.44-5.08 -1.84%
IXIC10,778.80-14.48 -0.13%

Immunovant Reports '8.0-point mean improvement on Myasthenia Gravis Composite (MGC) scale was highly statistically significant vs. placebo' And 'Mean reductions in total IgG from baseline for the 340 mg and 680 mg cohorts were 59% and 76%, respectively'

Benzinga · 08/25/2020 11:32